However, luteolin treatment significantly altered the formation of these mutant Htt inclusions, leading to a dramatic inhibition and prevention of aggregate and soluble Htt protein accumulation in the brain regions of HD mice (Figure 6C–E). This evidence concerns the gene HTT and Huntington disease.